• Skip to main content
  • Skip to footer
Eco Friendly CBD OIL

Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

  • Home
  • CBD Health
  • Cannabis News
  • Contact

CBD OIL

Maine Cannabis Retailers Sell $1.4 Million in First Month of Legal Sales

November 26, 2020 by CBD OIL

Portland, OR — PRESS RELEASE — At its regular monthly meeting on Nov. 19, 2020, the Oregon Liquor Control Commission (OLCC) approved eight recreational marijuana license stipulated settlements. Additionally, the City of Portland’s Cannabis Policy Oversight Team (CPOT) provided the Commission with an update on the Portland Cannabis Program.

CPOT reviewed its efforts to make equity the center of all decision-making efforts related to cannabis regulation, including ensuring that patients should have access to cannabis for medicinal purposes. CPOT is also reworking its cannabis grant program to focus on distributed funding to BIPOC recipients.

OLCC staff provided assessments of how two ballot measures approved by Oregon voters earlier this month could impact the agency.

Measure 109, which establishes a program for the therapeutic use of psilocybin mushrooms, directs the Oregon Health Authority (OHA) to enter into an agreement with the OLCC to use the state’s Cannabis Tracking System (CTS) to prevent psilocybin diversion from therapy program. OLCC has initiated conversations with its CTS vendor the OLCC has deferred further action, until OHA, currently busy with the pandemic, can begin implementing the program.

One provision of Measure 110 reclassifies some drug convictions which will impact the evaluation process of OLCC licensee and permitee applicants. Currently, the OLCC rarely makes a license or permit decision based solely on drug convictions, but there are differences between the OLCC’s alcohol and recreational marijuana licensing and permitting criteria that will now be reconciled; this might require the OLCC to enter into rulemaking.

The Commission also ratified the following violation fines and suspensions based on stipulated settlements (detailed information on specific cases can be found here on the OLCC website):

LA MOTA (#28CC) in Portland will serve an 18-day recreational marijuana retailer license suspension OR pay a fine of $2,970 fine for two violations.

Licensee is: La Mota, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

VIBRANT HIGHS will surrender its marijuana processor license suspension for one violation.

Licensees are: OGX, LLC; Paul Luttrell, Member; Jonathan Showker, Member; Kathy Cook, Member

LA MOTA FRONT AVE in Portland will serve a nine-day recreational marijuana retailer license suspension OR pay a fine of $1,485 fine for one violation.

Licensees are: La Mota Front Ave, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

EVIO LABS MEDFORD in Medford will surrender its recreational marijuana laboratory license suspension for four violations.

Licensees are: Smith Scientific Industries, Inc.; Anthony Smith, President/Director/Stockholder; William Waldrop, Secretary/Director; EVIO, Inc., Stockholder; Lori Glauser, Director/Stockholder; William Waldrop, Director/Stockholder

MR NICE GUY RETAIL in Corvallis will serve a 10-day recreational marijuana retailer license suspension OR pay a fine of $3,630 fine for two violations.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

MR NICE GUY RETAIL in Salem will pay a fine of $280 for one recreational marijuana retailer license violation.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

NECTAR in Salem will serve a seven-day recreational marijuana retailer license suspension OR pay a fine of $1,155 fine for two violations.

Licensees are: Nectar Markets, LLC; Nectar Holdings, Inc., Member; Jeremy Pratt, President/Director/Stockholder; Jeffrey Johnson, Vice-President; Michael Olson, Secretary/Treasurer

ALBION FARMS will serve an 18-day recreational marijuana producer license suspension OR pay a fine of $2,970 fine for two violations.

Licensees are: MediRec, LLC; Vandaly Industries, Inc., Member; Eric Buckner, President

Filed Under: Cannabis News

Give the Gift of Wellness This Holiday Season: Veritas Farms, Inc. Launches Limited Holiday Edition Four-Pack of Full Spectrum Hemp Oil Tinctures, Featuring Seasonal Flavors

November 26, 2020 by CBD OIL

Fort Lauderdale, Fla. ― Oct. 21, 2020 ― Veritas Farms, Inc. (OTCQB: VFRM) ― a vertically-integrated agribusiness focused on the production of full spectrum hemp extracts with naturally occurring cannabinoids ― is making the holidays even brighter with its limited edition, seasonal four-pack of full spectrum hemp oil tinctures. The four-pack will be available at www.theveritasfarms.com/holiday-cbd-tinctures on Nov. 2, 2020.

Embracing the holiday spirit, the holiday bundle features four seasonal flavors: Cranberry Orange, Clementine Spice, Sugar Plum and Cinnamon Roll. The fast-acting CBD oil tinctures contain full spectrum hemp oil, which is extracted from the flowers and leaves of hemp plants grown on Veritas Farms’ Colorado farm. For only $49.99, the bundle includes all four flavors of tinctures in 15mL bottles with 250mg’s of full spectrum hemp oil per bottle. One serving offers 25mg’s of full spectrum hemp oil, so customers will receive an extra strength dose for the holidays.

Alexander M. Salgado, CEO and co-founder of Veritas Farms, said, “There is no better gift than good health. This limited edition four-pack of seasonal full spectrum hemp oil tinctures is a unique holiday gift idea that is sure to bring joy to those who receive it. Not only does it invoke the spirit of the holidays, but also a much-needed calming effect.”

At Veritas Farms’ 140-acre farm and production facility in Pueblo, Colorado, the brand controls all of its growing, extracting and manufacturing to ensure the quality, potency and freshness of its full spectrum hemp oil. Its products come straight from the farm to the customer’s door step.

All Veritas Farms brand products are third-party laboratory tested for strength and purity. All packaging includes a batch-unique QR code linking to verifiable Certificates of Analysis from an approved scientific testing laboratory. Veritas Farms is registered with the Colorado Department of Agriculture to grow industrial hemp.

Veritas Farms products are currently available online at www.theveritasfarms.com. They are also currently available in 8,000 brick-and-mortar locations, as well as through online retailers across the country. This includes major retail stores such as Kroger Family of Stores, Rite aid CVS Pharmacy, Fruth Pharmacy, Neiman’s Family Market, and Bartell Drugs.

 

About Veritas Farms, Inc.

Veritas Farms, Inc. (OTCQB: VFRM) is a vertically integrated agribusiness focused on producing superior quality, whole plant, full spectrum hemp oils and extracts containing naturally occurring cannabinoids.  The Company currently operates a 140-acre farm and production facilities in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp.  The Company markets and sells products under its Veritas Farms™ brand and manufactures private label products for a number of leading distributors and retailers.

Veritas Farms™ brand full spectrum hemp oil products include vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, and oral syringes in a variety of size formats and flavors.  All Veritas Farms™ brand products are third-party laboratory tested for strength and purity.  The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.

For additional information and online product purchase, visit www.theveritasfarms.com.

Veritas Farms, Inc. – Investor Contact

Toll-Free: (888) 549-7888

E-mail: ir@theveritasfarms.com

Filed Under: CBD Health

California Judge Rules Cannabis Billboards Are Illegal Under Prop. 64

November 26, 2020 by CBD OIL

Portland, OR — PRESS RELEASE — At its regular monthly meeting on Nov. 19, 2020, the Oregon Liquor Control Commission (OLCC) approved eight recreational marijuana license stipulated settlements. Additionally, the City of Portland’s Cannabis Policy Oversight Team (CPOT) provided the Commission with an update on the Portland Cannabis Program.

CPOT reviewed its efforts to make equity the center of all decision-making efforts related to cannabis regulation, including ensuring that patients should have access to cannabis for medicinal purposes. CPOT is also reworking its cannabis grant program to focus on distributed funding to BIPOC recipients.

OLCC staff provided assessments of how two ballot measures approved by Oregon voters earlier this month could impact the agency.

Measure 109, which establishes a program for the therapeutic use of psilocybin mushrooms, directs the Oregon Health Authority (OHA) to enter into an agreement with the OLCC to use the state’s Cannabis Tracking System (CTS) to prevent psilocybin diversion from therapy program. OLCC has initiated conversations with its CTS vendor the OLCC has deferred further action, until OHA, currently busy with the pandemic, can begin implementing the program.

One provision of Measure 110 reclassifies some drug convictions which will impact the evaluation process of OLCC licensee and permitee applicants. Currently, the OLCC rarely makes a license or permit decision based solely on drug convictions, but there are differences between the OLCC’s alcohol and recreational marijuana licensing and permitting criteria that will now be reconciled; this might require the OLCC to enter into rulemaking.

The Commission also ratified the following violation fines and suspensions based on stipulated settlements (detailed information on specific cases can be found here on the OLCC website):

LA MOTA (#28CC) in Portland will serve an 18-day recreational marijuana retailer license suspension OR pay a fine of $2,970 fine for two violations.

Licensee is: La Mota, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

VIBRANT HIGHS will surrender its marijuana processor license suspension for one violation.

Licensees are: OGX, LLC; Paul Luttrell, Member; Jonathan Showker, Member; Kathy Cook, Member

LA MOTA FRONT AVE in Portland will serve a nine-day recreational marijuana retailer license suspension OR pay a fine of $1,485 fine for one violation.

Licensees are: La Mota Front Ave, LLC, Co-Licensee; Aaron Mitchell, Member; Rosa Cazares, Co-Licensee

EVIO LABS MEDFORD in Medford will surrender its recreational marijuana laboratory license suspension for four violations.

Licensees are: Smith Scientific Industries, Inc.; Anthony Smith, President/Director/Stockholder; William Waldrop, Secretary/Director; EVIO, Inc., Stockholder; Lori Glauser, Director/Stockholder; William Waldrop, Director/Stockholder

MR NICE GUY RETAIL in Corvallis will serve a 10-day recreational marijuana retailer license suspension OR pay a fine of $3,630 fine for two violations.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

MR NICE GUY RETAIL in Salem will pay a fine of $280 for one recreational marijuana retailer license violation.

Licensees are: MNG Holdings, LLC; Michael NG, Member; Patrick Martin, Member

NECTAR in Salem will serve a seven-day recreational marijuana retailer license suspension OR pay a fine of $1,155 fine for two violations.

Licensees are: Nectar Markets, LLC; Nectar Holdings, Inc., Member; Jeremy Pratt, President/Director/Stockholder; Jeffrey Johnson, Vice-President; Michael Olson, Secretary/Treasurer

ALBION FARMS will serve an 18-day recreational marijuana producer license suspension OR pay a fine of $2,970 fine for two violations.

Licensees are: MediRec, LLC; Vandaly Industries, Inc., Member; Eric Buckner, President

Filed Under: Cannabis News

Digital Holiday Sales Are Already Up & Expected to Climb, Particularly for CBD Brands

November 26, 2020 by CBD OIL

Amazon recently reported that the small and midsize businesses that sell on its marketplace made more than $3.5 billion during Prime Day. That’s a 60% increase over last year’s sales according to CNBC.

Although holiday shoppers’ wallets are billions of dollars lighter this year, there are still plenty of sales opportunities for market-savvy cannabidiol (CBD) brands.

Now Is The Time

Timing is everything, and the time to run holiday digital sales promotions is now.

Deloitte expects holiday e-commerce sales to surge by 25% to 35% with volume peaking between November to January.

And a survey by Coresight Research reports that three in 10 consumers expect to start their holiday shopping earlier than usual.

COVID-cautious Consumer Spending

With 31 million holiday travelers grounded this year and more than 47% of families reporting they are downsizing holiday events, this year’s holiday season will be dominated by “remote giving.”

Holiday shoppers’ traditional buying preferences and patterns are shifting in concert.

The three P’s of the promotional period–products, pricing, and promotions–don’t apply this year. This season is all about a brand’s preparation, perception, and pursuit, according to Michael Brown, a consumer market expert at Kearney.

CBD companies’ websites should be festive, fun, and filled with tons of sensational gift bundles.                Brands should invest more time in packaging and marketing offers. Banners like “great gifts for moms” and “deals for dads” provide purchasing cues that are likely to convert to higher-than-average cart size.

Remote givers are looking for smaller, more practical and attractively packaged gift bundles that convey as much warmth and sentiment as can be packed and shipped.

And they want their packages to arrive on time.

Shipping Slow Downs

Surges in online shopping are putting new demands on shippers, which are already straining to keep up with increased demand. CBD brands need to examine their shipping systems and have back-up plans in place.

Understand your delivery agent’s mailing performance and adjust customer promises accordingly. We recommend that brands create an automated customer shipping update to inform customers of any projected shipping delays. And, if service delays are anticipated, proactively issue special discounts or offers to recognize the inconvenience.

One way to avoid these predictable bottlenecks is to kick off holiday campaigns (and shipments) now to avoid the rush.

Gifts Cards Are On Trend

The most popular gift this year will likely be gift cards, according to Morning Consult, which reports that 48% of adults plan to buy or give gift cards this holiday season.

Three times as many shoppers said they will spend most on gift cards versus the next-highest gift type, clothing.

“The trend is real and it’s working,” says Scott Zabka, a CBD storeowner using CBD Marketing Hub to run live gift card campaigns.

According to Zabka the majority of recipients have become repeat customers.

We agree with the growing body of retail experts that recommend that brands examine promotional strategies to avoid over-discounting products–a move that ultimately drives down pricing and profitability.

Gift cards typically offer similar value to BOGO promotions but add a valuable kicker. They look and spend like cash, and consumers are more likely to redeem them and return to restock.

A Growing Need for Self-Care

The importance of self-care has become evident as a result of the pandemic and has risen to become one of the largest trends in the US.

Nearly one-third of consumers increased their self-care behavior this past year, according to IRI, which reports that nearly nine out of 10 Americans (88%) practice some form of self-care.

Many companies, including Austra, CBD for Life, Green Roads, Uncle Bud’s Hemp, and some Your CBD Store owners, are boosting their digital storefronts and in-store offers. Green Roads’ Self-care Deluxe Bundle is among trending gift items.

“[It’s] a really great gift, especially for stressed-out moms who need a break,” says Lee Sosin, CMO of Green Roads.

CBD for Life plans to leverage the trend with a co-branded promotion with Moonlit Skincare, according to Julie Redfern, the company’s director of marketing.

In order to help brands leverage the trend, CBD Marketing Hub created a cost-free small business icon for unrestricted use by CBD brands.

Big Growth

The importance of seasonal holiday sales has risen. Once considered a key part of many leading CBD brands’ growth strategies, this year’s fourth quarter holiday sales have the potential to re-order the marketplace.

Consumer preferences for smaller, more practical gifts, coupled with the elevated importance of self-care create a unique opportunity for CBD brands to do better than good this holiday season.

Image Credit: Daria Yakovleva

Image Source: https://pixabay.com/photos/christmas-new-year-s-eve-postcard-1911637/

Filed Under: CBD Health

West Virginia Issues 10 Medical Cannabis Processing Licenses

November 26, 2020 by CBD OIL

BOCA RATON, Fla., Nov. 23, 2020 (GLOBE NEWSWIRE) — PRESS RELEASE — Jushi Holdings Inc., a vertically integrated, multi-state cannabis operator, has announced plans to nearly double the square footage of its subsidiary’s grower-processor facility in Scranton, Pa., from approximately 90,000 sq. ft. to more than 160,000 sq. ft. in a phased expansion. The majority of the approximate 70,000 sq. ft. expansion project will be focused on increasing the facility’s canopy space, which upon completion will nearly triple to approximately 98,000 sq. ft. The first phase of the expansion is expected to come online in mid-2021 and the final phase will be completed by the second quarter of 2022. In total, Jushi expects to invest approximately $50 million on the expansion project, which is expected to create over 100 new jobs in the Scranton area. Jushi (through its subsidiary Pennsylvania Medical Solutions, LLC), will work with Innovative Industrial Properties, Inc. (through its subsidiary IIP-PA 1 LLC) to partially finance the expansion project via an upsize to the existing lease agreement between the parties. The expansion project is subject to the company’s successful completion of certain milestones, including receipt of all local and state approvals and permits, and the finalization of a mutually agreed lease amendment with Innovative Industrial Properties Inc. related to the facility.

“The medical cannabis market in Pennsylvania is rapidly growing and with our products in high-demand, this investment will significantly expand our cultivation capacity and market share,” said Jim Cacioppo, chief executive officer, chairman and founder of Jushi. “This is a robust operating environment and with the market intelligence gained through our eight currently operating BEYOND / HELLO retail dispensaries, we believe that patient demand for high-quality, medical grade cannabis products is still far from being satisfied. With the phased build out, the support of our financing partner Innovative Industrial Properties, Inc., and our strong balance sheet with ample liquidity, we expect to remain fully funded to operating cash flow positive, including our likely investment beyond Innovative Industrial Properties, Inc.’s support. We believe that by investing in the expansion of our grower-processors, we will generate the greatest potential return for Jushi shareholders.”

Cacioppo concluded, “We are very excited by the opportunity ahead of us in Pennsylvania, and as one of the fastest growing jobs sectors in the U.S., Jushi and its subsidiaries look forward to bringing additional new local jobs and tax dollars to the region and further investing in Scranton’s economy and community.”

The company recently completed an expansion project in the third quarter 2020, which included increasing the Facility’s indoor cultivation from approximately 20,000 sq. ft. to approximately 45,000 sq. ft. (~33,000 sq. ft. of canopy) and supplementing the current CO2 extraction with new Class I, Division 1 ethanol extraction technology. The facility produces high-quality, indoor grown flower and extracts and is strategically located within minutes of Interstate 81, Interstate 84 and the Pennsylvania Turnpike, enabling efficient wholesale distribution to the 98 dispensaries currently operating across the commonwealth, including the company’s eight operational BEYOND / HELLO dispensaries. The facility is expected to supply the company’s subsidiaries, and other licensed retail facilities.

Filed Under: Cannabis News

Oleamide: Intriguing Endocannabinoid Effects – CBD Health and Wellness

November 26, 2020 by CBD OIL

Oleamide is fatty acid amide found in the nervous system of mammals, with research indicating it can play a role in sleep induction. The process in which this occurs seems to involve the endocannabinoid system (ECS) and in particular the cannabinoid 1 (CB1) receptor. To better understand oleamide, we looked at a research review summarizing the evidence to date.

Pre-clinical studies have shown that oleamide is found in the cerebrospinal fluid during periods of sleep deprivation and that it has the ability to help encourage sleep.[1] Since oleamide is also found within human blood plasma, the possibility exists that the same effects might occur in humans.

To explore this possibility, an understanding of how oleamide uptake occurs within the central nervous system is necessary. Researchers used an agent known to block the CB1 receptor that also prevents other cannabinoid actions such as analgesia and memory disruption.[1]

The use of this receptor blocker eliminated the sleep-inducing and hypnotic effects of oleamide.[1] The amide was still present at levels that helped induce sleep under previous observation but these data indicates that oleamide is, in part, mediated through ECS pathways.

The presence of oleamide in human blood plasma demonstrates the potential for the compound to be further studied and analyzed for potential sleep inducing and calming benefits. Research into this human potential is lacking but the pre-clinical study described here shows another intriguing function and purpose of the ECS found within mammals. However, the review also pointed out that oleamide works with other systems in the brain, similar to how cannabidiol (CBD) has a widespread effect, not limited to the ECS.[1]

As we gain a better understanding of the ECS and how different compounds and substances, such as oleamide, interact with it, we stand to unlock further insight into this fascinating system found within the human body.

Sleep deprivation affects so many people, especially during this time of economic instability and other stressors associated with the pandemic. A natural way to induce sleep is greatly needed and further research will allow us to better understand safer ways to get those Zs.

Image Credit: Enrique Meseguer

Image Source: https://pixabay.com/illustrations/fantasy-dream-magic-female-child-4040384/

Reference

  1. Mendelson WB & Basile AS. The hypnotic actions of the fatty acid amide, oleamide. Neuropsychopharmacology. 2001 Nov;25(5 Suppl):S36-9.

Filed Under: CBD Health

Cannabis Won Big: A Post-Election Analysis

November 26, 2020 by CBD OIL

Editor’s Note: This article has been updated to include the presidential and congressional election results.


While the votes continue to come in for the presidential and congressional elections and we have some concrete results materializing, cannabis legalization has emerged as a clear winner across the board. Five states had initiatives on the ballot to legalize cannabis in one form or another and voters in all five states approved those measures by wide margins.

As of this writing, 15 states now have legalized adult use cannabis and 36 states have legalized medical cannabis. That is a significant portion of the United States with some form of legal cannabis, even without counting the emergent hemp markets across the country.

After a tight race and mail-in vote counts diminishing President Trump’s lead days following the election, Joe Biden has won the White House. Most cannabis industry stakeholders see this as a win for cannabis as both Biden and Vice President-Elect Kamala Harris have voiced support for federal decriminalization of cannabis. The vocal support is very much so tied to their campaign on ending racial injustices and systemic racism, citing the failed war on drugs for disproportionately harming communities of color.

While it is looking like the Democrats will retain control of the House of Representatives, it is still unclear which party will control the Senate. That  question likely won’t be answered until January 2021, when voters in Georgia will decide on two Senate seats in runoff elections that will decide which party gets the majority. With a Democratic majority in the House and Senate, it is entirely possible that the Biden administration could decriminalize cannabis on a federal level within the next four years. Without that majority, however, it is possible reform could come at a much slower pace.

As more states legalize cannabis, their neighbors see the potential economic benefits and want to cash in on the movement. Just take a look at the West Coast.

Comments made by politicians leading up to the election in the Northeast also shed some light on the alleged domino effect coming to the United States. In late October, about two weeks before the election, New York Governor Andrew Cuomo was asked when his state will legalize adult use cannabis. His answer: “Soon, because now we need the money.” Back in September, Pennsylvania Governor Tom wolf specifically asked the state legislature to legalize adult use cannabis. Governor Wolf said “people will go to New Jersey” to purchase cannabis once it becomes legal in the neighboring state.

Question 1 in NJ won by a very wide margin

Well, New Jersey legalized adult use cannabis. So now it appears we are in a waiting game to see which neighboring state will move forward before the other. Alyssa Jank, consulting services manager at Brightfield Group, predicts cannabis sales in New Jersey to reach about $460 million in 2021, up from about $94 million this year. She says the market could reach $1.5 billion by 2025.

Sam D’Arcangelo, director of the Cannabis Voter Project, a division of HeadCount, says the New Jersey measure is pretty bare-bones, so the legislature will need to pass enabling legislation that actually creates the adult-use program. “It’s tough to tell exactly what that legislation will look like or how long it will take to pass, but it’s possible it will be approved pretty quickly,” says D’Arcangelo. “Tonight’s results could set off a domino effect that inspires lawmakers to move forward with legalization in a number of states throughout the region.”

Let’s take a closer look at Arizona: Back in 2016, Arizona had a measure on the ballot to legalize adult use cannabis that failed to get enough votes. Things have clearly changed in the state in the last four years because Prop. 207 (the 2020 ballot initiative to legalize adult use cannabis) won 59.8% to 40.2%. Arizona now joins a massive West Coast bloc of states slowly creeping inland that have legalized adult use cannabis, including, Washington, Oregon, California, Nevada and now Arizona, not to mention Montana. Drug Policy Alliance’s Emily Kaltenbach believes that New Mexico will follow suit as well, with three out of four voters in the state in favor of it.

Voters in Mississippi approved a medical cannabis program by a wide margin with almost 74% in favor. Even more encouraging, voters in the state rejected the legislature’s attempt to hijack the initiative with their own alternative measure that would have involved developing their own program as they see fit without any sort of deadline.

While Montana can tend to lean slightly Democrat, it is surrounded by heavily Republican-dominated states like Wyoming and Idaho. With both Montana and South Dakota voters approving adult use legalization measures, this presents a potential inroad for cannabis to reach far more conservative states in the Northern Rockies and beyond.

Greg Kaufman Partner at Eversheds Sutherland and frequent Cannabis Industry Journal contributor, says this election puts considerable pressure on Congress to take some action on one or more of the cannabis-related bills currently pending. “In several states, cannabis was more popular than the winning presidential candidate, regardless of the party of the winning candidate,” says Kaufman. “This suggests that cannabis is not a partisan issue, nor should it be.”

The 15 states that have legal adult use cannabis now represents about 34% of the population in our country. “During the most divisive election in modern U.S. history, Americans demonstrated unity around at least one issue – cannabis policy reform,” says Aaron Smith, co-founder and chief executive officer of the National Cannabis Industry Association. He says the victories we saw this week are commendable and will lead to a lot of new jobs, tax revenue and thousands of fewer arrests, but there is still a lot of work to be done. “We look forward to building on this progress as we continue to work with Congress to end the conflict between outdated federal laws and the growing number of states with regulated cannabis markets, and help undo the racially and economically disparate harms caused by prohibition.”

While we wait to hear who will control the Senate in 2021, which will have a massive impact on cannabis reform, we leave you with this great quote from Aaron Smith: “There is still a lot of work to do, but the wind is at our backs.”

To see the details and results of each cannabis measure on the ballot in this election, click here. 

Filed Under: Cannabis News

How Topicals May Treat Atopic Dermatitis

November 26, 2020 by CBD OIL

Topical products are a unique way to administer cannabidiol (CBD) and other cannabinoids. Topicals possess many advantages as an alternative method, as patients who are not comfortable with broadcasting their cannabis use to the world can use lotions or creams discreetly. Topicals are also beneficial for targeting certain areas like the hands, back, or legs.

Topicals can also take effect rapidly, as they bypass the stomach and digestive system, going straight through the skin to bloodstream.[1] But the benefits of topicals don’t stop there. In fact, for some dermatological conditions, topicals might actually exert its effects by enhancing function of the skin barrier.

Atopic dermatitis (AD) is a condition characterized by chronic inflammation and uncomfortable itching. Research on the mechanism of AD has revealed damage to skin barrier function due to the effects of pro-inflammatory substances like cytokines.[2]

Several cannabinoids are effective at relieving AD symptoms, likely due to their anti-inflammatory properties.[3,4] Studies have dug further to better understand the mechanism underlying these effects.

Treatment with oxazolone solution (1% in acetone) mimics the effects of AD in pre-clinical models. Using this technique, as well as cell assays, researchers found that cannabinoid 1 (CB1) receptor agonists (which increase the function of the receptor) inhibited the production of inflammatory compounds linked to AD.[5]

An additional study employing the same AD model confirmed these findings. However, researchers also found that CB1 agonists significantly accelerated and improved skin barrier recovery.[2]

These results support the use of cannabinoids like palmitoyl ethanolamide, or PEA. In fact, this endocannabinoid has been used to treat dermatological conditions like AD.[6] While PEA is a CB2 agonist, it stimulates anandamide, another endocannabinoid, to activate the CB1 receptor. These actions in turn alleviate itch.[3,4,6]

While there are many benefits of topical use, a greater understanding of how cannabinoids exert their effects on dermatological conditions like AD may help when choosing the right therapy. For example, knowing which cannabis compounds work directly via the CB1 receptor or CB2 can help you in discussing a plan with your doctor or dispensary.

It’s also important to keep in mind the benefits of the “entourage effect,” or the power of full-spectrum cannabis brought on by both cannabinoids and terpenes.[7] So, if you haven’t used topicals before, trying out different products may be best to determine what works best for you and your condition.

Image Credit: Skeeze

 Image Source: https://pixabay.com/photos/clasped-hands-comfort-hands-black-541849/

References

  1. Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4(8):1770-1804.
  2. Kim HJ, et al. Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model. Int J Dermatol. 2015;54(10):e401-408.
  3. Sheriff T, et al. The potential role of cannabinoids in dermatology. J Dermatolog Treat. 2020;31(8):839-845.
  4. Eagleston LRM, et al. Cannabinoids in dermatology: a scoping review. Dermatol Online J. 2018;24(6):13030.
  5. Nam G, et al. Selective cannabinoid receptor-1 agonists regulate mast cell activation in an oxazolone-induced atopic dermatitis model. Ann Dermatol. 2016;28(1):22-29.
  6. Borrelli F, et al. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. Br J Pharmacol. 2015;172(1):142-158.
  7. Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.

Filed Under: CBD Health

Law Enforcement Files Lawsuit Against South Dakota’s Voter-Approved Adult-Use Cannabis Legalization Measure

November 26, 2020 by CBD OIL

VANCOUVER, BC, Nov. 23, 2020 /CNW/ – PRESS RELEASE – Village Farms International, Inc. has announced two positive developments with respect to its wholly owned Canadian cannabis subsidiary, Pure Sunfarms.

Pure Sunfarms Receives Cannabis Research License for On-Site Sensory Evaluation from Health Canada

Pure Sunfarms has received from Health Canada its Cannabis Research License to conduct human administration trials for sensory evaluation of cannabis, enabling it to engage in on-site assessments of the taste, sight, smell or touch of its products at its Delta 3 cannabis facility in Delta, British Columbia.

“This license provides us with significant new opportunities in the formulation and refinement of our products, and underscores our commitment to innovation and the advancement of the Canadian cannabis consumer experience,” said Mandesh Dosanjh, president and chief executive officer of Pure Sunfarms. “We look forward to leveraging this new capability to continue to extend Pure Sunfarms’ product leadership and further strengthen what is already one of Canada’s best-selling cannabis brands.”

Pure Sunfarms Brand Debuts Internationally in Hong Kong

Pure Sunfarms will be featured as part of a limited-edition Lane Crawford x Found CBD-infused gift set to be sold in the luxury department store’s holiday pop-up shops in Hong Kong this holiday season. The luxury gift sets will feature Pure Sunfarms branded CBD gummies created specifically for the Hong Kong consumer, among other CBD-inspired items such as chocolates, bath salts, and tea bags. The co-branded Lane Crawford and Found holiday pop-up shops aim to educate consumers and elevate their awareness of CBD.

The inclusion of Pure Sunfarms-branded CBD products was facilitated through a partnership between Altum International Limited’s Found, Asia-Pacific’s first CBD retail platform and café, and Lane Crawford, an iconic luxury department store in Greater China. In August 2020, Village Farms acquired 6.6% of Australia-based Altum, one of the Asia-Pacific’s leading cannabinoid platforms.

“We’re so pleased for the Pure Sunfarms’ brand to make its debut internationally, alongside such prestigious and progressive partners as Altum and Lane Crawford,” said Dosanjh. “This is just the beginning of what’s to come for Pure Sunfarms as we look to share our love of plants and B.C.-grown cannabis products with the global cannabis market.”

“We are particularly excited to be able to present in Asia-Pacific for the first time, Pure Sunfarms, Canada’s market-leading cannabis brand,” Fiachra Mullen, chief marketing officer for Altum International. “We believe that the leading cannabis brands in the Canadian market will hold a special place in the Hong Kong consumer’s heart. We are incredibly proud to have their trust in helping them access the Asia-Pacific markets for the first time through the most progressive cannabinoid jurisdiction in the region – Hong Kong.”

Filed Under: Cannabis News

What Is CBD Paste? – CBD Health and Wellness

November 26, 2020 by CBD OIL

The rising popularity of cannabidiol (CBD) means there are always new CBD products hitting the market.

You may be familiar with gummies, oils, and capsules. Did you know that there’s another form of CBD called CBD paste?

Below, we take a closer look at CBD paste and how it compares to other CBD products.

What is CBD paste?

CBD paste is similar to other CBD products in that it contains CBD, but it differs a lot in terms of potency. It’s usually much more concentrated than other types of CBD.

Some companies add CBD paste to oils like MCT oil.

CBD paste is a good option for people who want or need to take higher doses of CBD, whether for a specific condition or because smaller doses don’t quite do the trick.

What does the research say about CBD?

While the research on CBD is still coming out, what we know so far suggests that CBD might have a few benefits.

Some research points to CBD as a potential treatment for pain because it affects cannabinoid receptor activity and reduces inflammation.

Another study found that CBD may also help with pain related to multiple sclerosis (MS) and arthritis.

However, this study used Sativex, a type of prescription CBD spray not approved for use in the United States. Sativex also contains tetrahydrocannabinol (THC), the psychoactive compound in cannabis, which may contribute to its effects.

Some people also take CBD to help with:

Evidence also suggests that CBD may help with cancer-related pain and chemotherapy-induced nausea and vomiting.

Additionally, CBD can help people with certain kinds of epilepsy. Epidiolex is currently the only drug approved by the Food and Drug Administration (FDA) that contains CBD. It’s available by prescription and specifically intended to treat epilepsy.

Other animal and human studies suggest that CBD may also:

  • Have antipsychotic effects. A 2015 review found this to be the case, though researchers note that more studies are needed.
  • Have anti-tumor effects. This was noted in a 2015 research review, but again, more research is needed.
  • Help with substance use treatment. A small review found that CBD may help with addiction to certain substances, including opioids, cocaine, and tobacco.

Benefits and drawbacks of CBD paste

You might be wondering, why choose CBD paste over other forms of CBD, like gummies or capsules? Here are some advantages of CBD paste:

  • It’s a more effective way to take CBD in high doses (instead of taking several gummies or capsules, for example).
  • You need to take a smaller amount to get a higher dosage, which can help you avoid additives.
  • It’s often more cost effective.
  • You can use it to make your own edibles or CBD products.

However, there are also several drawbacks of CBD paste compared to other forms of CBD.

It’s a little harder to figure out dosage with paste. It often comes in syringe form. Because it’s hard to dispense, it’s easy to take too much, which can increase your risk for experiencing side effects.

Paste also has a strong taste. The paste-like consistency means you might end up with it stuck to your teeth and gums.

How to shop for CBD paste

Here’s what you should look for when shopping for CBD products like CBD paste.

CBD source

You can choose between CBD isolate and full-spectrum or broad-spectrum CBD. If you prefer to stay away from THC, opt for an isolate. Know that by choosing an isolate, you’re not getting the full benefit of the entourage effect.

Potency

CBD paste is a lot more potent than other types of CBD. Keep this in mind when buying and taking it. It may not be the best product for people new to CBD.

Third-party testing

The FDA can take action against CBD companies that make false claims about their products.

But the FDA doesn’t currently guarantee that any over-the-counter CBD products are safe or effective. So, how can you be sure you’re buying a quality CBD product that is what it says it is?

Look for a certificate of analysis (COA). This means that the CBD paste has been tested for all sorts of contaminants, like pesticides, heavy metals, and molds.

The COA can also tell you whether the advertised potency is accurate or not, as well as which cannabinoids the product contains.

Hemp source

Look for companies that source their hemp in the United States, since U.S. hemp is subject to certain agricultural regulations. Bonus points for hemp that’s U.S.-certified organic.

Customer reviews

Look at customer reviews to get a sense of whether the company and its products have a good reputation. Reviews are a great baseline. If people are repeatedly mentioning the same problem, it’s usually a sign that that’s something to pay attention to.

How to use CBD paste

If CBD paste is already mixed with a carrier oil like MCT oil, you take it like you would a CBD oil.

Most CBD paste, though, comes in a syringe. You can push it out and add it to foods or beverages, or eat it straight from the syringe.

Because CBD paste is a lot more concentrated than gummies or oil, start off with a tiny amount. Remember, it can take some time to feel the effects of edible products.

Eloise Theisen, RN, full-time medical cannabis program faculty at the Pacific College of Health and Science, and president of the American Cannabis Nurses Association, suggests swallowing the paste instead of letting it dissolve under your tongue.

The longer it’s in your mouth, the higher the chance of the stuff sticking to your teeth and gums, which can feel unpleasant and delay its effects.

You can find out more about dosage by checking out our article on CBD dosage.

Safety and side effects

While research suggests that CBD is generally considered safe, some people can experience adverse effects, like:

  • fatigue
  • weight loss or gain
  • appetite change
  • diarrhea

Don’t forget to talk to your healthcare provider before taking any kind of CBD. It can interact with certain medications.

Also avoid taking CBD alongside high fat foods or meals. One study found that doing so might increase your risk for side effects.

Takeaway

If you’re finding it hard to take high doses of CBD with traditional gummies and oil, you may want to try CBD paste.

This cannabis-derived extract is a lot more concentrated, making it easier for people looking to take a high dose of CBD.

People with chronic pain or dealing with pain or nausea due to cancer and chemotherapy may need higher doses of CBD to feel any noticeable effects.

When shopping for CBD paste, look for a reputable company that provides customers with a comprehensive COA.

Is CBD Legal? Hemp-derived CBD products (with less than 0.3 percent THC) are legal on the federal level, but are still illegal under some state laws. Marijuana-derived CBD products are illegal on the federal level, but are legal under some state laws. Check your state’s laws and those of anywhere you travel. Keep in mind that nonprescription CBD products are not FDA-approved, and may be inaccurately labeled.

Image Credit: Julia Teichmann

Image Source: https://pixabay.com/photos/cbd-cbd-kapseln-cannabidiol-4474928/

Original Article: https://www.healthline.com/health/cbd-paste#takeaway

Filed Under: CBD Health

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 110
  • Go to page 111
  • Go to page 112
  • Go to page 113
  • Go to page 114
  • Interim pages omitted …
  • Go to page 116
  • Go to Next Page »

Footer

  • Home
  • Privacy Policy
  • Terms of Service